PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
XGES.L vs. XDWT.L
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


XGES.LXDWT.L
YTD Return0.79%10.65%
1Y Return-2.69%40.64%
Sharpe Ratio-0.102.12
Daily Std Dev33.27%18.76%
Max Drawdown-37.90%-35.99%
Current Drawdown-27.97%-2.72%

Correlation

-0.50.00.51.00.5

The correlation between XGES.L and XDWT.L is 0.53, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

XGES.L vs. XDWT.L - Performance Comparison

In the year-to-date period, XGES.L achieves a 0.79% return, which is significantly lower than XDWT.L's 10.65% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%60.00%December2024FebruaryMarchAprilMay
-22.41%
60.08%
XGES.L
XDWT.L

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C

Xtrackers MSCI World Information Technology UCITS ETF 1C

XGES.L vs. XDWT.L - Expense Ratio Comparison

XGES.L has a 0.35% expense ratio, which is higher than XDWT.L's 0.25% expense ratio.


XGES.L
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C
Expense ratio chart for XGES.L: current value at 0.35% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.35%
Expense ratio chart for XDWT.L: current value at 0.25% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.25%

Risk-Adjusted Performance

XGES.L vs. XDWT.L - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGES.L) and Xtrackers MSCI World Information Technology UCITS ETF 1C (XDWT.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


XGES.L
Sharpe ratio
The chart of Sharpe ratio for XGES.L, currently valued at -0.10, compared to the broader market0.002.004.00-0.10
Sortino ratio
The chart of Sortino ratio for XGES.L, currently valued at 0.10, compared to the broader market-2.000.002.004.006.008.0010.000.10
Omega ratio
The chart of Omega ratio for XGES.L, currently valued at 1.02, compared to the broader market0.501.001.502.002.501.02
Calmar ratio
The chart of Calmar ratio for XGES.L, currently valued at -0.09, compared to the broader market0.005.0010.00-0.09
Martin ratio
The chart of Martin ratio for XGES.L, currently valued at -0.33, compared to the broader market0.0020.0040.0060.0080.00-0.33
XDWT.L
Sharpe ratio
The chart of Sharpe ratio for XDWT.L, currently valued at 2.12, compared to the broader market0.002.004.002.12
Sortino ratio
The chart of Sortino ratio for XDWT.L, currently valued at 2.92, compared to the broader market-2.000.002.004.006.008.0010.002.92
Omega ratio
The chart of Omega ratio for XDWT.L, currently valued at 1.36, compared to the broader market0.501.001.502.002.501.36
Calmar ratio
The chart of Calmar ratio for XDWT.L, currently valued at 3.24, compared to the broader market0.005.0010.003.24
Martin ratio
The chart of Martin ratio for XDWT.L, currently valued at 8.58, compared to the broader market0.0020.0040.0060.0080.008.58

XGES.L vs. XDWT.L - Sharpe Ratio Comparison

The current XGES.L Sharpe Ratio is -0.10, which is lower than the XDWT.L Sharpe Ratio of 2.12. The chart below compares the 12-month rolling Sharpe Ratio of XGES.L and XDWT.L.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2024FebruaryMarchAprilMay
-0.10
2.12
XGES.L
XDWT.L

Dividends

XGES.L vs. XDWT.L - Dividend Comparison

Neither XGES.L nor XDWT.L has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

XGES.L vs. XDWT.L - Drawdown Comparison

The maximum XGES.L drawdown since its inception was -37.90%, which is greater than XDWT.L's maximum drawdown of -35.99%. Use the drawdown chart below to compare losses from any high point for XGES.L and XDWT.L. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%December2024FebruaryMarchAprilMay
-24.80%
-2.72%
XGES.L
XDWT.L

Volatility

XGES.L vs. XDWT.L - Volatility Comparison

The current volatility for Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGES.L) is 5.62%, while Xtrackers MSCI World Information Technology UCITS ETF 1C (XDWT.L) has a volatility of 7.31%. This indicates that XGES.L experiences smaller price fluctuations and is considered to be less risky than XDWT.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%December2024FebruaryMarchAprilMay
5.62%
7.31%
XGES.L
XDWT.L